About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 989837, 17 pages
http://dx.doi.org/10.1155/2013/989837
Review Article

Role of HLA, KIR, MICA, and Cytokines Genes in Leprosy

1Program of Biosciences Applied to Pharmacy, Department of Clinical Analysis and Biomedicine, Maringa State University, Avenida Colombo 5790, 87020-900 Maringá, PR, Brazil
2Basic Health Sciences Department, Maringa State University, Avenida Colombo 5790, 87020-900 Maringá, PR, Brazil

Received 20 March 2013; Revised 16 May 2013; Accepted 5 June 2013

Academic Editor: Enrique Medina-Acosta

Copyright © 2013 Luciana Ribeiro Jarduli et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. A. Hansen, “Baccilus leprae,” Norsk Mag Laegevidenskaben, vol. 9, pp. 1–21, 1874.
  2. World Health Organization, “Global leprosy situation,” Weekly Epidemiological Record, vol. 85, p. 337, 2010.
  3. D. S. Ridley and W. H. Jopling, “Classification of leprosy according to immunity. A five-group system,” International Journal of Leprosy and Other Mycobacterial Diseases, vol. 34, no. 3, pp. 255–273, 1966. View at Scopus
  4. D. M. Scollard, L. B. Adams, T. P. Gillis, J. L. Krahenbuhl, R. W. Truman, and D. L. Williams, “The continuing challenges of leprosy,” Clinical Microbiology Reviews, vol. 19, no. 2, pp. 338–381, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. P. E. M. Fine, “Natural history of leprosy: aspects relevant to a leprosy vaccine,” International Journal of Leprosy, vol. 51, no. 4, pp. 553–555, 1983. View at Scopus
  6. E. Schurr, A. Alcaïs, L. de Léséleuc, and L. Abel, “Genetic predisposition to leprosy: a major gene reveals novel pathways of immunity to Mycobacterium leprae,” Seminars in Immunology, vol. 18, no. 6, pp. 404–410, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. E. Thorsby, T. Godal, and B. Myrvang, “HLA antigens and susceptibility to diseases. II. Leprosy,” Tissue Antigens, vol. 3, no. 5, pp. 373–377, 1973. View at Scopus
  8. A. Dasgupta, N. K. Mehra, S. K. Ghei, and M. C. Vaidya, “Histocompatibility antigens (HLA) in leprosy,” Tissue Antigens, vol. 5, no. 2, pp. 85–87, 1975. View at Scopus
  9. J. Greiner, E. Schleiermacher, and T. Smith, “The HLA system and leprosy in Thailand,” Human Genetics, vol. 42, no. 2, pp. 201–213, 1978. View at Scopus
  10. N. Mohagheghpour, H. Tabatabai, and K. Mohammad, “Histocompatibility antigens in patiens with leprosy from Azarbaijan, Iran,” International Journal of Leprosy, vol. 47, no. 4, pp. 597–600, 1979. View at Scopus
  11. U. M. Bale, M. M. Mehta, and N. M. Contractor, “HLA antigens in leprosy patients,” Tissue Antigens, vol. 20, no. 2, pp. 141–143, 1982. View at Scopus
  12. S. Izumi, K. Sugiyama, Y. Matsumoto, and S. Ohkawa, “Analysis of the immunogenetic background of Japanese leprosy patients by the HLA system,” Vox Sanguinis, vol. 42, no. 5, pp. 243–247, 1982. View at Scopus
  13. S. J. Kim, I. H. Choi, and S. Dahlberg, “HLA and leprosy in Koreans,” Tissue Antigens, vol. 29, no. 3, pp. 146–153, 1987. View at Scopus
  14. J. N. Agrewala, S. K. Ghei, K. S. Sudhakar, B. K. Girdhar, and U. Sengupta, “HLA antigens and erythema nodosum leprosum (ENL),” Tissue Antigens, vol. 33, no. 4, pp. 486–487, 1989. View at Scopus
  15. R. Rani, S. A. Zaheer, and R. Mukherjee, “Do human leukocyte antigens have a role to play in differential manifestation of multibacillary leprosy: a study on multibacillary leprosy patients from North India,” Tissue Antigens, vol. 40, no. 3, pp. 124–127, 1992. View at Scopus
  16. L.-M. Wang, A. Kimura, M. Satoh, and S. Mineshita, “HLA linked with leprosy in southern China; HLA-linked resistance alleles to leprosy,” International Journal of Leprosy and Other Mycobacterial Diseases, vol. 67, no. 4, pp. 403–408, 1999. View at Scopus
  17. M. Koçak, M. Balci, B. Pençe, and N. Kundakçi, “Associations between human leukocyte antigens and leprosy in the Turkish population,” Clinical and Experimental Dermatology, vol. 27, no. 3, pp. 235–239, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. U. Shankarkumar, K. Ghosh, S. Badakere, and D. Mohanty, “Novel HLA class I alleles. Associated with Indian leprosy patients,” Journal of Biomedicine and Biotechnology, vol. 3, pp. 208–211, 2003.
  19. U. Shankarkumar, “HLA associations in leprosy patients from Mumbai, India,” Leprosy Review, vol. 75, no. 1, pp. 79–85, 2004. View at Scopus
  20. D. S. A. Franceschi, L. T. Tsuneto, P. S. Mazini et al., “Class-I human leukocyte alleles in leprosy patients from southern Brazil,” Revista da Sociedade Brasileira de Medicina Tropical, vol. 44, no. 5, pp. 616–620, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Alter, N. T. Huong, M. Singh et al., “Human leukocyte antigen class I region single-nucleotide polymorphisms are associated with leprosy susceptibility in Vietnam and India,” The Journal of Infectious Diseases, vol. 203, no. 9, pp. 1274–1281, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. V. Schauf, S. Ryan, and D. Scollard, “Leprosy associated with HLA-DR2 and DQw1 in the population of northern Thailand,” Tissue Antigens, vol. 26, no. 4, pp. 243–247, 1985. View at Scopus
  23. M. Cem Mat, H. Yazici, F. Ozbakir, and Y. Tuzun, “The HLA association of lepromatous leprosy and borderline lepromatous leprosy in Turkey. A preliminary study,” International Journal of Dermatology, vol. 27, no. 4, pp. 246–247, 1988. View at Scopus
  24. N. K. Mehra, W. Verduijn, V. Taneja, J. Drabbels, S. P. N. Singh, and M. J. Giphart, “Analysis of HLA-DR2-associated polymorphisms by oligonucleotide hybridization in an Asian Indian population,” Human Immunology, vol. 32, no. 4, pp. 246–253, 1991. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Rani, M. A. Fernandez-Vina, S. A. Zaheer, K. R. Beena, and P. Stastny, “Study of HLA class II alleles by PCR oligotyping in leprosy patients from North India,” Tissue Antigens, vol. 42, no. 3, pp. 133–137, 1993. View at Scopus
  26. N. K. Mehra, R. Rajalingam, D. K. Mitra, V. Taneja, and M. J. Giphart, “Variants of HLA-DR2/DR51 group haplotypes and susceptibility to tuberculoid leprosy and pulmonary tuberculosis in Asian Indians,” International Journal of Leprosy, vol. 63, no. 2, pp. 241–248, 1995. View at Scopus
  27. L. Zerva, B. Cizman, N. K. Mehra et al., “Arginine at position 13 or 70-71 in pocket 4 of HLA-DRB1 alleles is associated with susceptibility to tuberculoid leprosy,” The Journal of Experimental Medicine, vol. 183, no. 3, pp. 829–836, 1996. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Soebono, M. J. Giphart, G. M. T. Schreuder, P. R. Klatser, and R. R. P. de Vries, “Associations between HLA-DRB1 Alleles and Leprosy in an Indonesian Population,” International Journal of Leprosy and Other Mycobacterial Diseases, vol. 65, no. 2, pp. 190–196, 1997. View at Scopus
  29. J. E. L. Visentainer, L. T. Tsuneto, M. F. Serra, P. R. F. Peixoto, and M. L. Petzl-Erler, “Association of leprosy with HLA-DR2 in a Southern Brazilian population,” Brazilian Journal of Medical and Biological Research, vol. 30, no. 1, pp. 51–59, 1997. View at Scopus
  30. S. Joko, J. Numaga, H. Kawashima, M. Namisato, and H. Maeda, “Human leukocyte antigens in forms of leprosy among Japanese patients,” International Journal of Leprosy and Other Mycobacterial Diseases, vol. 68, no. 1, pp. 49–56, 2000. View at Scopus
  31. M.-A. Shaw, I. J. Donaldson, A. Collins et al., “Association and linkage of leprosy phenotypes with HLA class II and tumour necrosis factor genes,” Genes and Immunity, vol. 2, no. 4, pp. 196–204, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. A. A. Hegazy, I. A. Abdel-Hamid, E.-S. F. Ahmed, S. M. Hammad, and S. A. Hawas, “Leprosy in a high-prevalence Egyptian village: epidemiology and risk factors,” International Journal of Dermatology, vol. 41, no. 10, pp. 681–686, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. K. Tosh, M. Ravikumar, J. T. Bell, S. Meisner, A. V. S. Hill, and R. Pitchappan, “Variation in MICA and MICB genes and enhanced susceptibility to paucibacillary leprosy in South India,” Human Molecular Genetics, vol. 15, no. 19, pp. 2880–2887, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. P. M. F. Motta, N. Cech, C. Fontan et al., “Role of HLA-DR and HLA-DQ alleles in multibacillary leprosy and paucibacillary leprosy in the province of Chaco (Argentina),” Enfermedades Infecciosas y Microbiologia Clinica, vol. 25, no. 10, pp. 627–631, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Singh, A. Balamurugan, K. Katoch, S. K. Sharma, and N. K. Mehra, “Immunogenetics of mycobacterial infections in the North Indian population,” Tissue Antigens, vol. 69, supplement 1, pp. 228–230, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. P. R. Vanderborght, A. G. Pacheco, M. E. Moraes et al., “HLA-DRB1* 04 and DRB1* 10 are associated with resistance and susceptibility, respectively, in Brazilian and Vietnamese leprosy patients,” Genes and Immunity, vol. 8, no. 4, pp. 320–324, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. S. G. Borrás, C. Cotorruelo, L. Racca et al., “Association of leprosy with HLA-DRB1 in an Argentinean population,” Annals of Clinical Biochemistry, vol. 45, no. 1, pp. 96–98, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. F. Zhang, H. Liu, S. Chen, et al., “Evidence for an association of HLA-DRB1*15 and DRB1*09 with leprosy and the impact of DRB1*09 on disease onset in a Chinese Han population,” BMC Medical Genetics, vol. 10, p. 133, 2009.
  39. S. A. da Silva, P. S. Mazini, P. G. Reis et al., “HLA-DR and HLA-DQ alleles in patients from the south of Brazil: markers for leprosy susceptibility and resistance,” BMC Infectious Diseases, vol. 9, pp. 134–140, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. N.-K. Hsieh, C.-C. Chu, N.-S. Lee, H.-L. Lee, and M. Lin, “Association of HLA-DRB1*0405 with resistance to multibacillary leprosy in Taiwanese,” Human Immunology, vol. 71, no. 7, pp. 712–716, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. R. Lavado-Valenzuela, M. José Bravo, A. P. Junqueira-Kipnis et al., “Distribution of the HLA class II frequency alleles in patients with leprosy from the mid-west of Brazil,” International Journal of Immunogenetics, vol. 38, no. 3, pp. 255–258, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. R. D. G. Corrêa, D. M. Aquino, A. d. J. Caldas, et al., “Association analysis of human leukocyte antigen class II, (DRB1) alleles with leprosy in individuals from São Luís, state of Maranhão, Brazil,” Memórias Instituto Oswaldo Cruz, vol. 107, supplement 1, pp. 150–155, 2012.
  43. A. R. Santos, A. S. Almeda, P. N. Suffys et al., “Tumor necrosis factor promoter polymorphism (TNF2) seems to protect against development of severe forms of leprosy in a pilot study in Brazilian patients,” International Journal of Leprosy and Other Mycobacterial Diseases, vol. 68, no. 3, pp. 325–327, 2000. View at Scopus
  44. M. O. Moraes, N. C. Duppre, P. N. Suffys et al., “Tumor necrosis factor-α promoter polymorphism TNF2 is associated with a stronger delayed-type hypersensivity reaction in the skin of borderline tuberculoid leprosy patients,” Immunogenetics, vol. 53, no. 1, pp. 45–47, 2001. View at Publisher · View at Google Scholar · View at Scopus
  45. A. R. Santos, P. N. Suffys, P. R. Vanderborght et al., “Role of tumor necrosis factor-α and interleukin-10 promoter gene polymorphisms in leprosy,” The Journal of Infectious Diseases, vol. 186, no. 11, pp. 1687–1691, 2002. View at Publisher · View at Google Scholar · View at Scopus
  46. D. S. A. Franceschi, P. S. Mazini, C. C. C. Rudnick et al., “Influence of TNF and IL10 gene polymorphisms in the immunopathogenesis of leprosy in the south of Brazil,” International Journal of Infectious Diseases, vol. 13, no. 4, pp. 493–498, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. C. C. Cardoso, A. C. Pereira, V. N. Brito-de-Souza et al., “TNF -308G>A single nucleotide polymorphism is associated with leprosy among Brazilians: a genetic epidemiology assessment, meta-analysis, and functional study,” The Journal of Infectious Diseases, vol. 204, no. 8, pp. 1256–1263, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. B. R. Sapkota, M. Macdonald, W. R. Berrington et al., “Association of TNF, MBL, and VDR polymorphisms with leprosy phenotypes,” Human Immunology, vol. 71, no. 10, pp. 992–998, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. S. Roy, W. McGuire, C. G. N. Mascie-Taylor et al., “Tumor necrosis factor promoter polymorphism and susceptibility to lepromatous leprosy,” The Journal of Infectious Diseases, vol. 176, no. 2, pp. 530–532, 1997. View at Scopus
  50. S. Vejbaesya, P. Mahaisavariya, P. Luangtrakool, and C. Sermduangprateep, “TNF α and NRAMP1 polymorphisms in leprosy,” Journal of the Medical Association of Thailand, vol. 90, no. 6, pp. 1188–1192, 2007. View at Scopus
  51. G. Levée, E. Schurr, and J. P. Pandey, “Tumor necrosis factor-alpha, interleukin-1-beta and immunoglobulin (GM and KM) polymorphisms in leprosy. A linkage study,” Experimental and Clinical Immunogenetics, vol. 14, no. 2, pp. 160–165, 1997. View at Scopus
  52. J. S. Velarde-Félix, S. Cázarez-salazar, J. J. Ríos-Tostado, A. Flores-Garcia, H. Rangel-Villalobos, and J. Murillo-Llanes, “Lack of effects of the TNF-alpha and IL-10 gene polymorphisms in Mexican patients with lepromatous leprosy,” Leprosy Review, vol. 83, no. 1, pp. 34–39, 2012.
  53. S. Ali, R. Chopra, S. Aggarwal et al., “Association of variants in BAT1-LTA-TNF-BTNL2 genes within 6p21.3 region show graded risk to leprosy in unrelated cohorts of Indian population,” Human Genetics, vol. 131, no. 5, pp. 703–716, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. A. C. Pereira, V. N. Brito-de-Souza, C. C. Cardoso et al., “Genetic, epidemiological and biological analysis of interleukin-10 promoter single-nucleotide polymorphisms suggests a definitive role for -819C/T in leprosy susceptibility,” Genes and Immunity, vol. 10, no. 2, pp. 174–180, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. N. Cardona-Castro, M. Sánchez-Jiménez, W. Rojas, and G. Bedoya-Berrío, “IL-10 gene promoter polymorphisms and leprosy in a Colombian population sample,” Biomédica, vol. 32, pp. 71–76, 2012.
  56. M. O. Moraes, A. G. Pacheco, J. J. M. Schonkeren et al., “Interleukin-10 promoter single-nucleotide polymorphisms as markers for disease susceptibility and disease severity in leprosy,” Genes and Immunity, vol. 5, no. 7, pp. 592–595, 2004. View at Publisher · View at Google Scholar · View at Scopus
  57. D. Malhotra, K. Darvishi, S. Sood et al., “IL-10 promoter single nucleotide polymorphisms are significantly associated with resistance to leprosy,” Human Genetics, vol. 118, no. 2, pp. 295–300, 2005. View at Publisher · View at Google Scholar · View at Scopus
  58. G. Morahan, G. Kaur, M. Singh et al., “Association of variants in the IL12B gene with leprosy and tuberculosis,” Tissue Antigens, vol. 69, supplement 1, pp. 234–236, 2007. View at Publisher · View at Google Scholar · View at Scopus
  59. S.-B. Lee, B. C. Kim, S. H. Jin et al., “Missense mutations of the interleukin-12 receptor beta 1(IL12RB1) and interferon-gamma receptor 1 (IFNGR1) genes are not associated with susceptibility to lepromatous leprosy in Korea,” Immunogenetics, vol. 55, no. 3, pp. 177–181, 2003. View at Publisher · View at Google Scholar · View at Scopus
  60. H. Ohyama, N. Kato-Kogoe, F. Nishimura et al., “Differential effects of polymorphisms in the 5′ flanking region of IL12RB2 on NK- and T-cell activity,” Journal of Interferon and Cytokine Research, vol. 28, no. 9, pp. 563–569, 2008. View at Publisher · View at Google Scholar · View at Scopus
  61. A. Alvarado-Navarro, M. Montoya-Buelna, J. F. Muñoz-Valle, R. I. López-Roa, C. Guillén-Vargas, and M. Fafutis-Morris, “The 3′UTR 1188 A/C polymorphism in the interleukin-12p40 gene (IL-12B) is associated with lepromatous leprosy in the west of Mexico,” Immunology Letters, vol. 118, no. 2, pp. 148–151, 2008. View at Publisher · View at Google Scholar · View at Scopus
  62. V.-F. Jesús Salvador, R.-M. José Guadalupe, O.-R. Luis Antonio, and R.-V. Héctor, “Lack of association between 3′ UTR 1188 A/C polymorphism in the IL-12p40 gene and lepromatous leprosy in Sinaloa, México,” International Journal of Dermatology, vol. 51, no. 7, pp. 875–876, 2012. View at Publisher · View at Google Scholar · View at Scopus
  63. H. Liu, A. Irwanto, H. Tian, et al., “Identification of IL18RAP/IL18R1 and IL12B as leprosy risk genes demonstrates shared pathogenesis between inflammation and infectious diseases,” American Journal of Human Genetics, vol. 91, no. 5, pp. 935–941, 2012. View at Publisher · View at Google Scholar
  64. C. C. Cardoso, A. C. Pereira, V. N. Brito-De-Souza et al., “IFNG +874 T>A single nucleotide polymorphism is associated with leprosy among Brazilians,” Human Genetics, vol. 128, no. 5, pp. 481–490, 2010. View at Publisher · View at Google Scholar · View at Scopus
  65. D. Wang, J.-Q. Feng, Y.-Y. Li et al., “Genetic variants of the MRC1 gene and the IFNG gene are associated with leprosy in Han Chinese from Southwest China,” Human Genetics, vol. 131, no. 7, pp. 1251–1260, 2012. View at Publisher · View at Google Scholar · View at Scopus
  66. G. A. V. Silva, M. P. Santos, I. Mota-Passos, et al., “IFN-c +875 microsatellite polymorphism as a potential protection marker for leprosy patients from Amazonas state, Brazil,” Cytokine, vol. 60, pp. 493–497, 2012. View at Publisher · View at Google Scholar
  67. M. P. Reynard, D. Turner, A. P. Junqueira-Kipnis, M. R. de Souza, C. Moreno, and C. V. Navarrete, “Allele frequencies for an interferon-γ microsatellite in a population of Brazilian leprosy patients,” European Journal of Immunogenetics, vol. 30, no. 2, pp. 149–151, 2003. View at Publisher · View at Google Scholar · View at Scopus
  68. A. A. Velayati, P. Farnia, S. Khalizadeh, A. M. Farahbod, M. Hasanzadh, and M. F. Sheikolslam, “Case report: interferon-gamma receptor-1 gene promoter polymorphisms and susceptibility to leprosy in children of a single family,” American Journal of Tropical Medicine and Hygiene, vol. 84, no. 4, pp. 627–629, 2011. View at Publisher · View at Google Scholar · View at Scopus
  69. D. Yang, H. Song, W. Xu et al., “Interleukin 4-590T/C polymorphism and susceptibility to leprosy,” Genetic Testing and Molecular Biomarkers, vol. 15, no. 12, pp. 877–881, 2011. View at Publisher · View at Google Scholar · View at Scopus
  70. S. Aggarwal, S. Ali, R. Chopra et al., “Genetic variations and interactions in anti-inflammatory cytokine pathway genes in the outcome of leprosy: a study conducted on a MassARRAY platform,” The Journal of Infectious Diseases, vol. 204, no. 8, pp. 1264–1273, 2011. View at Publisher · View at Google Scholar · View at Scopus
  71. M. T. Mira, “Genetic host resistance and susceptibility to leprosy,” Microbes and Infection, vol. 8, no. 4, pp. 1124–1131, 2006. View at Publisher · View at Google Scholar · View at Scopus
  72. P. R. Vanderborght and C. C. Cardoso, “Susceptibilidade genética na hanseníase,” in Estudos de Associação HLA x Doenças; II Simpósio Brasileiro, p. 97, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil, 2009.
  73. M. Ravikumar, V. Dheenadhayalan, K. Rajaram et al., “Associations of HLA-DRB1, DQB1 and DPB1 alleles with pulmonary tuberculosis in south India,” Tubercle and Lung Disease, vol. 79, no. 5, pp. 309–317, 1999. View at Publisher · View at Google Scholar · View at Scopus
  74. H. Ohyama, S. Matsushita, F. Nishimura et al., “T cell responses to major membrane protein II (MMP II) of Mycobacterium leprae are restricted by HLA-DR molecules in patients with leprosy,” Vaccine, vol. 20, no. 3-4, pp. 475–482, 2001. View at Publisher · View at Google Scholar · View at Scopus
  75. G. P. Uko, L.-Y. Lu, M. A. Asuquo et al., “HLA-DRB1 leprogenic motifs in Nigerian population groups,” Clinical and Experimental Immunology, vol. 118, no. 1, pp. 56–62, 1999. View at Publisher · View at Google Scholar · View at Scopus
  76. J. N. Agrewala and R. J. Wilkinson, “Influence of HLA-DR on the phenotype of CD4+ T lymphocytes specific for an epitope of the 16-kDa alpha-crystallin antigen of Mycobacterium tuberculosis,” European Journal of Immunology, vol. 29, pp. 1753–1761, 1999.
  77. T. Mutis, Y. E. Cornelisse, G. Datema, P. J. van den Elsen, T. H. M. Ottenhoff, and R. R. P. de Vries, “Definition of a human suppressor T-cell epitope,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 20, pp. 9456–9460, 1994. View at Scopus
  78. W. F. C. Rigby, M. Waugh, and R. F. Graziano, “Regulation of human monocyte HLA-DR and CD4 antigen expression, and antigen presentation by 1,25-dihydroxyvitamin D3,” Blood, vol. 76, no. 1, pp. 189–197, 1990. View at Scopus
  79. S. V. Ramagopalan, N. J. Maugeri, L. Handunnetthi et al., “Expression of the multiple sclerosis-associated MHC class II allele HLA-DRB1*1501 is regulated by vitamin D,” PLoS Genetics, vol. 5, no. 2, Article ID e1000369, 2009. View at Publisher · View at Google Scholar · View at Scopus
  80. M. Bléry, L. Olcese, and E. Vivier, “Early signaling via inhibitory and activating NK receptors,” Human Immunology, vol. 61, no. 1, pp. 51–64, 2000. View at Publisher · View at Google Scholar · View at Scopus
  81. E. O. Long, “Regulation of immune responses through inhibitory receptors,” Annual Review of Immunology, vol. 17, pp. 875–904, 1999. View at Publisher · View at Google Scholar · View at Scopus
  82. D. S. A. Franceschi, P. S. Mazini, C. C. C. Rudnick et al., “Association between killer-cell immunoglobulin-like receptor genotypes and leprosy in Brazil,” Tissue Antigens, vol. 72, no. 5, pp. 478–482, 2008. View at Publisher · View at Google Scholar · View at Scopus
  83. H. G. Shilling, L. A. Guethlein, N. W. Cheng et al., “Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype,” Journal of Immunology, vol. 168, no. 5, pp. 2307–2315, 2002. View at Scopus
  84. C. M. Gardiner, L. A. Guethlein, H. G. Shilling et al., “Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism,” Journal of Immunology, vol. 166, no. 5, pp. 2992–3001, 2001. View at Scopus
  85. J. Trowsdale, “Genetic and functional relationships between MHC and NK receptor genes,” Immunity, vol. 15, no. 3, pp. 363–374, 2001. View at Publisher · View at Google Scholar · View at Scopus
  86. P. Parham, “MHC class I molecules and KIRS in human history, health and survival,” Nature Reviews Immunology, vol. 5, no. 3, pp. 201–214, 2005. View at Publisher · View at Google Scholar · View at Scopus
  87. S. Bahram, M. Bresnahan, D. E. Geraghty, and T. Spies, “A second lineage of mammalian major histocompatibility complex class I genes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 14, pp. 6259–6263, 1994. View at Publisher · View at Google Scholar · View at Scopus
  88. C. Leelayuwat, D. C. Townend, M. A. Degli-Esposti, L. J. Abraham, and R. L. Dawkins, “A new polymorphic and multicopy MHC gene family related to nonmammalian class I,” Immunogenetics, vol. 40, no. 5, pp. 339–351, 1994. View at Scopus
  89. T. Shiina, G. Tamiya, A. Oka et al., “Molecular dynamics of MHC genesis unraveled by sequence analysis of the 1,796,938-bp HLA class I region,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 23, pp. 13282–13287, 1999. View at Publisher · View at Google Scholar · View at Scopus
  90. N. W. Zwirner, M. A. Fernández-Viña, and P. Stastny, “MICA, a new polymorphic HLA-related antigen, is expressed mainly by keratinocytes, endothelial cells, and monocytes,” Immunogenetics, vol. 47, no. 2, pp. 139–148, 1998. View at Publisher · View at Google Scholar · View at Scopus
  91. S. Bauer, V. Groh, A. Steinle et al., “Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA,” Science, vol. 285, no. 5428, pp. 727–729, 1999. View at Publisher · View at Google Scholar · View at Scopus
  92. J. Wu, Y. Song, A. B. H. Bakker et al., “An activating immunoreceptor complex formed by NKG2D and DAP10,” Science, vol. 285, no. 5428, pp. 730–732, 1999. View at Publisher · View at Google Scholar · View at Scopus
  93. M. Gannagé, A. Buzyn, S. I. Bogiatzi et al., “Induction of NKG2D ligands by gamma radiation and tumor necrosis factor-α may participate in the tissue damage during acute graft-versus-host disease,” Transplantation, vol. 85, no. 6, pp. 911–915, 2008. View at Publisher · View at Google Scholar · View at Scopus
  94. H. Yasuoka, Y. Okazaki, Y. Kawakami et al., “Autoreactive CD8+ cytotoxic T lymphocytes to major histocompatibility complex class I chain-related gene A in patients with Behçet's disease,” Arthritis and Rheumatism, vol. 50, no. 11, pp. 3658–3662, 2004. View at Publisher · View at Google Scholar · View at Scopus
  95. H. Suemizu, M. Radosavljevic, M. Kimura et al., “A basolateral sorting motif in the MICA cytoplasmic tail,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 5, pp. 2971–2976, 2002. View at Publisher · View at Google Scholar · View at Scopus
  96. W. Sergio do Sacramento, P. S. Mazini, D. A. S. Franceschi et al., “Frequencies of MICA alleles in patients from southern Brazil with multibacillary and paucibacillary leprosy,” International Journal of Immunogenetics, vol. 39, no. 3, pp. 210–215, 2012. View at Publisher · View at Google Scholar · View at Scopus
  97. T. Kasahara, J. J. Hooks, S. F. Dougherty, and J. J. Oppenheim, “Interleukin 2-mediated immune interferon (IFN-γ) production by human T cells and T cell subsets,” Journal of Immunology, vol. 130, no. 4, pp. 1784–1789, 1983. View at Scopus
  98. A. Alcaïs, M. Mira, J. L. Casanova, E. Shurr, and L. Abel, “Genetic dissection of immunity in leprosy,” Current Opinion in Immunology, vol. 17, no. 1, pp. 44–48, 2005.
  99. Y. Suh and J. Vijg, “SNP discovery in associating genetic variation with human disease phenotypes,” Mutation Research, vol. 573, no. 1-2, pp. 41–53, 2005. View at Publisher · View at Google Scholar · View at Scopus
  100. B. B. Aggarwal, A. Samanta, and M. Feldmann, “TNFα,” in Cytokine Reference: A compendium of Cytokines and Other Mediators of Host Defense, pp. 413–434, 2000.
  101. P. R. Vanderborght, H. J. Matos, A. M. Salles, et al., “Single nucleotide polymorphisms (SNPs) at -238 and -308 positions in the TNFalpha promoter: clinical and bacteriological evaluation in leprosy,” International Journal of Leprosy and Other Mycobacterial Diseases, vol. 72, no. 2, pp. 143–148, 2004.
  102. R. W. Malefyt, “IL-10,” in Cytokine Reference: A Compendium of Cytokines and Other Mediators of Host Defense, pp. 165–185, 2000.
  103. C. Esche, M. R. Shurin, and M. T. Lotze, “IL-12,” in Cytokine Reference: A Compendium of Cytokines and Other Mediators of Host Defense, pp. 187–201, 2000.
  104. A. Billiau and K. Vandenbroeck, “IFNG,” in Cytokine Reference: A Compendium of Cytokines and Other Mediators of Host Defense, pp. 641–688, 2000.
  105. T. Matsuda and T. Hirano, “IL-6,” in Cytokine Reference: A compendium of Cytokines and Other Mediators of Host Defense, pp. 537–563, 2000.
  106. L. Sousa, V. M. Fava, L. H. Sampaio, et al., “Genetic and immunological evidence implicates interleukin 6 as a susceptibility gene for leprosy type 2 reaction,” The Journal of Infectious Diseases, vol. 205, no. 9, pp. 1417–1424, 2012.
  107. F. R. Zhang, W. Huang, S. M. Chen, et al., “Genomewide association study of leprosy,” The New England Journal of Medicine, vol. 361, no. 27, pp. 2609–2618, 2009. View at Publisher · View at Google Scholar
  108. S. H. Wong, A. V. S. Hill, and F. O. Vannberg, “Genomewide association study of leprosy,” The New England Journal of Medicine, vol. 362, no. 15, pp. 1446–1447, 2010. View at Publisher · View at Google Scholar · View at Scopus
  109. S. H. Wong, S. Gochhait, D. Malhotra et al., “Leprosy and the adaptation of human toll-like receptor 1,” PLoS pathogens, vol. 6, Article ID e1000979, 2010. View at Scopus
  110. V. Grant, A. Alter, N. T. Huong, et al., “Crohn's disease susceptibility genes are associated with leprosy in the Vietnamese population,” The Journal Infectious Diseases, vol. 206, no. 11, pp. 1763–1767, 2012. View at Publisher · View at Google Scholar
  111. J. C. Barrett, S. Hansoul, D. L. Nicolae, et al., “Genome-wide association defines more than 30 distinct susceptibility loci for Crohn’s disease,” Nature Genetics, vol. 40, no. 8, pp. 955–962, 2008. View at Publisher · View at Google Scholar
  112. Q. Yang, H. Liu, H. -Q. Low, et al., “Chromosome 2p14 is Linked to Susceptiblility to leprosy,” PLoS One, vol. 7, no. 1, Article ID e29747, 2012.